Journal Title：Pharmacoepidemiology And Drug Safety

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include:

design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;

comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;

methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;

assessments of harm versus benefit in drug therapy;

patterns of drug utilization;

relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;

evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.

药物流行病学和药物安全的目的是为药物流行病学学科的数据、方法和意见的交流和评估提供一个国际论坛。该杂志发表同行评审的原始研究报告、特邀评论和各种客座社论和评论，涵盖药物流行病学的科学、医学、统计、法律和经济方面以及药物上市后监督。这些类别中的适当材料也可以考虑作为简要报告发布。

特别感兴趣的领域包括：

设计、分析、结果和解释着眼于特定药物、生物制品或医疗器械的益处或安全性的研究，包括药物警戒研究、上市后监测、药物经济学、患者安全、分子药物流行病学或任何其他研究药物流行病学的广阔领域；

与药品、生物制品和医疗器械相关的比较有效性研究。比较有效性研究是对预防、诊断、治疗和监测临床状况的替代方法的利弊进行比较的证据的生成和综合，因为这些方法在现实世界中得到了真正的应用；

与药物流行病学相关的方法学贡献，无论是原创贡献、对现有方法的评论，还是关于如何应用药物流行病学方法的教程；

评估药物治疗中的危害与益处；

药物使用模式；

药物流行病学与监管指南的制定和解释之间的关系；

评估与药品、生物制品和医疗器械相关的风险管理计划和项目。